Patents for C12P 21 - Preparation of peptides or proteins (112,499)
05/2009
05/21/2009US20090130107 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
05/21/2009US20090130105 Compositions that bind multiple epitopes of igf-1r
05/21/2009US20090130102 Methods for humanizing antibodies and humanized antibodies made thereby
05/21/2009US20090130095 Composition comprising tumor necrosis factor (CD40) specific immunoglobulin for treatment and prevention of autoimmune diseases
05/21/2009US20090130093 Binding member for gm-csf receptor
05/21/2009US20090130089 Anti-cd20 antibodies and methods of use
05/21/2009US20090130060 Modified Vitamin K Dependent Polypeptides
05/21/2009US20090130034 Re-engineered uv damage endonuclease, compositions and methods
05/20/2009EP2060634A1 Structure protein of adeno-associated virus with amended antigenity, production and application thereof
05/20/2009EP2060633A1 Mammalian artificial chromosomes
05/20/2009EP2060630A2 PCA3, PCA3 genes, and methods of use
05/20/2009EP2060628A1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
05/20/2009EP2059606A2 Fusion peptide therapeutic compositions
05/20/2009EP2059590A2 Methods for producing secreted polypeptides having biological activity
05/20/2009EP2059587A2 Laccases for pulp bio-bleaching
05/20/2009EP1978994A4 Bmp-7 variant compositions, methods and uses
05/20/2009EP1592789B1 Administration of transposon-based vectors to reproductive organs
05/20/2009EP1574521B1 Method of protecting of thiol groups in antibodies
05/20/2009EP1341912B1 Method for the identification and isolation of binding polypeptides from combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains
05/20/2009EP1163260B1 Process for partitioning of proteins
05/20/2009EP0651789B2 Method for preventing zoster and alleviating varicella related post-herpetic neuralgia
05/20/2009CN101437956A Humanized anti-CD20 monoclonal antibody
05/20/2009CN101437953A Diacylglycerol acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms
05/20/2009CN101437952A High eicosapentaenoic acid producing strains of yarrowia lipolytica
05/20/2009CN101437951A Docosahexaenoic acid producing strains of Yarrowia lipolytica
05/20/2009CN101434982A Method for preparing vegetable seed active peptide by microbial solid state fermentation
05/20/2009CN101434981A Method for preparing vegetable seed peptide with single bioactivity by microbial solid state fermentation
05/20/2009CN101434980A Preparation of rice bran short peptide
05/20/2009CN101434979A Method for extracting protein from cereal fine powder
05/20/2009CN101434647A Epitope/peptide recognized by hla-a2402-restricted ep/cam-specific ctl and use of the same
05/20/2009CN101434642A Method for preparing non-denaturation hogskin insoluble collagen powder
05/20/2009CN101433722A Fusions of cytokines and tumor targeting proteins
05/20/2009CN101433715A Modified chimeric polypeptides with improved pharmacokinetic properties
05/20/2009CN101433714A Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
05/20/2009CN101433591A Method for preparing composite glycopeptide of Ficus carica
05/20/2009CN100489115C Double-enzyme process for modified preparation of injection type soybean protein isolate
05/20/2009CN100489114C Low-cost production for peptides
05/20/2009CN100489105C Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector
05/20/2009CN100489102C T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
05/20/2009CN100489097C Method for preparing protein using endogenetic angiogenesis inhibitive factor Arresten gene
05/20/2009CN100489096C Escherichia expression system for secreting and expressing recombinant human epidermal growth factor
05/20/2009CN100489095C Transformant for producing secondary metabolite modified with functional group and novel biosynthesis genes
05/20/2009CN100489093C Protein and nuclear acid of antrodia camphoratu antioxidase and preparation method and use thereof
05/20/2009CN100488982C Methods of preparing monoclonal antibodies binding with beta-amyloid proteins and bringing the protein configuration conversion
05/20/2009CN100488563C Modified anti-EGFR antibody with reduced immunogenicity
05/20/2009CN100488562C Clotting factor VII or VIIa like molecules
05/19/2009US7534877 Non-M, non-O HIV-1 strains, fragments and uses
05/19/2009US7534876 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
05/19/2009US7534870 Stable pharmaceutical composition comprising erythropoietin
05/19/2009US7534869 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
05/19/2009US7534856 PRO19624 antibodies
05/19/2009US7534608 Exposing embryonic stem cells culture to cells expressing activin receptor-like kinase (ALK) receptor, transplanting tissues into mammal, recovering insulin secreting cells; endocrine cell therapy
05/19/2009US7534604 Fusion polypeptides capable of activating receptors
05/19/2009US7534597 Fermenting lactic acid in kluyveromyces for use in cosmetics, pharmaceuticals, plastics and food production
05/19/2009US7534594 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
05/19/2009US7534586 Method for producing biomass
05/19/2009US7534580 Invention identifies carrier protein to which PSP94 is bound (named PSP94-binding protein), its nucleic acid and amino acid sequences; use in diagnosis and prognosis of PSP94 related disease
05/19/2009US7534575 Method for detecting cancer using an antibody to Zcytor16
05/19/2009US7534572 Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue
05/19/2009US7534564 Methods and compositions for polypeptide engineering
05/19/2009US7534445 isolated nucleotide sequences and degenerate sequences encoding the high molecular weight HMW protein; vaccines; antibodies; vectors
05/19/2009US7534444 Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies
05/19/2009US7534436 Peptide fragments of the harp factor inhibiting angiogenesis
05/19/2009US7534432 Suppressing acitivity to treat musculodegenerative disease
05/19/2009US7534431 Targetting antibodies containing haptens, cleaning agent, and drug delivery agent; tissue-directed therapy; solid phase synthesis
05/19/2009US7534430 Administering monoclonal or polyclonal antibody to treat multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease
05/19/2009US7534427 Predosing with non-radiolabeled antibody not performed
05/19/2009CA2345024C Modified tgf-.beta. superfamily proteins
05/19/2009CA2209167C Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
05/14/2009WO2009061477A1 Production of gamma-hydroxybutyrate
05/14/2009WO2009061402A2 Methods and compounds for phototransfer
05/14/2009WO2009060961A1 West nile virus vaccine, and method for production thereof
05/14/2009WO2009060857A1 Method for producing membrane protein
05/14/2009WO2009060129A1 Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n-glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes
05/14/2009WO2009022900A3 A process to produce polypeptides from soybean
05/14/2009WO2008120107A3 Glycosylation of molecules
05/14/2009WO2005003299A3 Polynucleotides encoding novel guanylate binding proteins (gbp's)
05/14/2009WO2004097001A3 Novel bacillus 029cel cellulase
05/14/2009US20090124790 Chromatographic method and system for purifying a botulinum toxin
05/14/2009US20090124780 Nanoparticle chains and Preparation Thereof
05/14/2009US20090124560 Composition Containing Peptide as Active Ingredient
05/14/2009US20090124541 Method for the recovery and application of novel human defensins as biologically active proteins for the treatment of infections and other diseases
05/14/2009US20090124511 Antibody complexes and methods for immunolabeling
05/14/2009US20090124008 Peptides for use in culture media
05/14/2009US20090123999 Nucleotide sequences invovled in plant disease resistance
05/14/2009US20090123975 Feed media
05/14/2009US20090123974 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
05/14/2009US20090123973 Methods of Making Modular Fusion Protein Expression Products
05/14/2009US20090123972 Staphylococcal nuclease fusion proteins for the production of recombinant peptides
05/14/2009US20090123971 Compositions of aminoacyl-tRNA synthetase and uses thereof
05/14/2009US20090123970 Glycosylated mammalian ngal and use thereof
05/14/2009US20090123969 Novel fluorescent protein and gene encoding the same
05/14/2009US20090123968 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
05/14/2009US20090123967 Modified spider silk proteins
05/14/2009US20090123966 Hybrid portable origin of replication plasmids
05/14/2009US20090123965 Hydrolysis Process For Raw Materials From The Fishing And Slaughterhouse Industries And Tanks For Use Therein
05/14/2009US20090123945 Cholinergic/serotoninergic receptor and uses thereof
05/14/2009US20090123942 Electrophysiological assays using oocytes that express human enac and the use of phenamil to improve the effect of enac enhancers in assays using membrane potential reporting dyes
05/14/2009US20090123938 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist
05/14/2009US20090123911 Isolated staphylococcus dnax subunit and use thereof